Effect of antibiotics on platelet thromboplastic function and thrombin activity. 1978

M Nakahara

Carbenicillin (CB-PC), sulphobenzylpenicillin (SB-PC), ampicillin (AB-PC), benzylpenicillin (PCG), cefazolin (CEZ), cephalothin (CET) and cephaloridine (CER) were used in vitro for the experiments. Recalcification time was prolonged by AB-PC, SB-PC, CB-PC and CER at the 10(-2) and 10(-3) M level. Prothrombin time (PT) was prolonged by AB-PC, CEZ, CET and CER at the 10(-2) M level. Plasma antithrombin activity was not affected by any antibiotics tested at the 10(-2) and 10(-3) M level. The platelet thromboplastic function of the human platelet suspension and free platelet factor III were reduced more than 40% by all antibiotics used except for PCG at the 10(-3) M level compared with controls, showing no significant difference in the degree of reduction between these two samples. When antibiotics were preincubated with albumin solution, the reduction of platelet thromboplastic function was greatly inhibited except with CB-PC and CER. Factors of bleeding caused by intramuscular injections of the antibiotics are discussed.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010977 Platelet Factor 3 A phospholipid from the platelet membrane that contributes to the blood clotting cascade by forming a phospholipid-protein complex (THROMBOPLASTIN) which serves as a cofactor with FACTOR VIIA to activate FACTOR X in the extrinsic pathway of BLOOD COAGULATION. PF 3,Factor 3, Platelet
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin

Related Publications

M Nakahara
December 1958, The Australian journal of experimental biology and medical science,
M Nakahara
January 1966, Nouvelle revue francaise d'hematologie,
M Nakahara
February 1966, Australasian annals of medicine,
M Nakahara
November 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
M Nakahara
December 1957, Revue francaise d'etudes cliniques et biologiques,
M Nakahara
January 1972, Irish journal of medical science,
Copied contents to your clipboard!